KRAS and adenoma: The model of the progressive step-wise accumulation of genetic and epigenetic events required first for the development of adenoma and then of adenocarcinoma was instrumental for the identification of driver somatic mutations occurring at the level of some tumor suppressor genes (APC, TP53, SMAD4) and oncogenes (KRAS and PI3KCA).